ChristopherScottStaufferMD

Psychiatry • Vancouver, WA

Addiction

Resident Physician, Psychiatry, UCSF School of Medicine

Join to view full profile

Dr. Stauffer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stauffer's full profile

Already have an account?

Office
1601 E 4th Plain Blvd
V3SATP
Vancouver, WA 98661
Phone+1 360-696-4061

Fax+1 360-737-1419

Education & Training

University of California (San Francisco)Residency, Psychiatry, 2010 - 2014
Oregon Health and Science University School of MedicineClass of 2010

Certifications & Licensure

OR State Medical License 2020 - 2025
WA State Medical License 2022 - 2025
CA State Medical License 2011 - 2023
American Board of Psychiatry and Neurology Psychiatry
American Board of Preventive Medicine Addiction Medicine

Clinical Trials

Cocaine Opioid Oxytocin Option - Limited Start of enrollment: 2014 Jul 01
Completed
Phase 1
Stimulant Oxytocin Study Start of enrollment: 2018 Jan 26
Completed
Phase 2
Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans Start of enrollment: 2023 Sep 01
Withdrawn
Phase 2
Roles: Contact

Publications & Presentations

PubMed

1 citations
Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.
Philip Todd Korthuis, Kim Hoffman, Adrianne R Wilson-Poe, Jason B Luoma, Alissa Bazinet
Journal of Psychopharmacology. 2024-08-01
6 citations
Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.
Kelley C O'Donnell, Brian T Anderson, Frederick S Barrett, Michael P Bogenschutz, Charles S Grob
The American Journal of Psychiatry. 2024-01-01
3 citations
Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary.
Michael D Alpert, Kelley C O'Donnell, Casey A Paleos, Evan Sola, Evan Sola
The American Journal of Psychiatry. 2024-01-01

Press Mentions

New Study Establishes Best Practices for Supervised PsilocybinJune 19th, 2024
Illicit Drugs That Have Medicinal BenefitsJanuary 13th, 2023
'Magic Mushroom' Therapy: Does It Interact with Other Medicines?March 25th, 2022
Join now to see all